drugset

drugset / Trial / NCT00283764

Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device

NCT00283764 ↗

Phase 3 Withdrawn Viatris Inc.

RandomizedParallel-groupSingle-blindTreatment

Summary

Compare the antihypertensive efficacy of two methods for instilling Xalatan eyedrops

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Latanoprost	Small molecule	—	—

Indications